子分类：
| 序号 | 专利名 | 申请号 | 申请日 | 公开（公告）号 | 公开（公告）日 | 发明人 |
|---|---|---|---|---|---|---|
| 1 | Composition useful for healing and protecting skin | US58217 | 1998-04-10 | US6126950A | 2000-10-03 | Rattan Lal Bindra; Rashmi Gupta; Yogendra Nath Shukla; Samresh Dwivedi; Sushil Kumar |
| The present invention relates to a formulation of herbal cream for cracked heels and palms. Since the components in the formulation are from herbal sources it is very safe and eco-friendly and does not produce any harmful effects on the skin. It is comprised of a natural wax as an emulsifier, extract of curcuma and the gum of Acacia or Colophonium or Shorea. The gum gives a synergistic effect in binding and healing the skin with natural wound healing herbal extract selected from the aqueous extracts of curcuma, neem and allantonin. This is combined with a wound healing fragrant oil. The natural wound healing herbal extract acts as a humectant and the gum gives an synergistic effect in binding the skin thereby reducing water loss from the skin. The cream spreads evenly and smoothly when applied on the affected parts, and quickens healing, restores natural suppleness and softness and also serves as an antiseptic. | ||||||
| 2 | Anti-bacterial protein extracts from seeds of marigold and paprika | US57853 | 1998-04-09 | US6086885A | 2000-07-11 | Steve Ziegenfuss; Friedhelm Brinkhaus; John Greaves |
| The present invention describes the method of extraction and the effect of a crude protein extract from the seed tissue of two botanical species, Tagetes and Capsicum, on the survival of two economically important gram-negative bacteria Salmonella typhimurium and Escherichia coli. | ||||||
| 3 | Nontoxic extract of Larrea tridentata and method of making the same | US329359 | 1999-06-10 | US6039955A | 2000-03-21 | Robert A. Sinnott; W. Dennis Clark; Kenneth Frank DeBoer |
| A nontoxic, therapeutic agent having pharmacological activity comprising concentrated extract of Larrea tridentata plant material and ascorbic acid, an ascorbic acid ester, an ascorbic acid salt, butylated hydroxyanisole, butylated hydroxytoluene, hydrogen sulfide, hypophosphorous acid, monothioglycerol, potassium bisulfite, propyl gallate, sodium bisulfite, sodium hydrosulfite, sodium thiosulfate, sulfur dioxide, sulfurous acid, a tocopherol or vitamin E is made by a process in which the plant material is extracted using an organic solvent, preferably acetone, and is then saturated with one of the listed reducing agents acid to reduce the toxic NDGA quinone, which naturally occurs in the plant material, to NDGA itself. Additional amounts of ascorbic acid, an ascorbic acid ester, an ascorbic acid salt, butylated hydroxyanisole, butylated hydroxytoluene, hydrogen sulfide, hypophosphorous acid, monothioglycerol, potassium bisulfite, propyl gallate, sodium bisulfite, sodium hydrosulfite, sodium thiosulfate, sulfur dioxide, sulfurous acid, a tocopherol, or vitamin E may be added to the extract to inhibit the natural oxidation of the NDGA into the toxic NDGA quinone in vivo, or during processing or storage. The resulting extract is usefull in the treatment of viral diseases caused by viruses from the Herpesviridae family or viruses which require the Sp1 class of proteins to initiate viral replications. The resulting compound can also be used as an anti-inflammatory when the inflammatory diseases are mediated by the effects of leukotrienes. The listed reducing agents can also be used to stabilize NDGA as a therapeutic agent or a food additive. | ||||||
| 4 | Synergistic herbal extracts | US825798 | 1997-04-02 | US6027716A | 2000-02-22 | Orna Levin; Doron Friedman; Yochanan Forman; Michael Friedman |
| A synergistic anti-bacterial composition, including: (a) an extract of botanical materials, the botanical materials including material from Plantago species, Hypericum species, Echinacea species and Propolis; and (b) oil of cinnamon. | ||||||
| 5 | Usage of pathogen-killing foams | US668407 | 1996-06-21 | US6022545A | 2000-02-08 | H. B. Schmittmann; J. Dietrich |
| This invention describes the effect of a means to prevent the sexual transmission of infectious pathogens of the vaginal and uterine wall in women, farm animals and pets. This discovery concerns a means to disrupt the sexual transmission of infectious pathogens which attack the cavity living of the vagina and uterus of women, farm animals and pets which consists of a foam that prevents the docking of pathogens to the cavity lining and which acts as a pathogen-killing substance. | ||||||
| 6 | Cell proliferator and applications thereof | US947164 | 1997-10-08 | US6010701A | 2000-01-04 | Yumiko Matsukura; Kazuhiko Tokoro |
| A cell proliferator comprising as an active ingredient a distilled residue of an extract obtained by extracting one or more specific plants as raw materials of spicery with one or more solvents selected from the group consisting of water, lower alcohols, polyol type organic solvents, petroleum ether and hexane; a spicery composition comprising the cell proliferator; an external agent for skin comprising the cell proliferator; and a bathing agent comprising the cell proliferator. | ||||||
| 7 | Compositions of matter useful in the treatment of viral infections derived from plant extracts | US890065 | 1997-07-09 | US5989556A | 1999-11-23 | Hsiu-Hsien Tsai; Shie-Ming Hwang |
| Compositions derived from Chinese herbal medicines, medicinal plants and extracts thereof, are provided for the treatment of animals infected with viruses, especially with hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV). More specifically, the compositions of the present invention are derived from various Chinese herbal medicines or medicinal plants which have a long history of human consumption. The compositions of the invention are obtained through specific techniques and have demonstrated outstanding efficacy for treating human HBV carriers and hepatitis C patients. Compositions according to the invention have also exhibited in vitro antiviral activities against murine leukemia virus (MuLV) and HIV. HIV is the virus known to cause acquired immunodeficiency syndrome (AIDS) in humans and AIDS presents special problems to the medical community which the present invention addresses. Preferred compositions contain the herbal ingredients AEGINETIAE HERBA, BLECHNI RHIZOMA, LESPEDEZAE HERBA, POLYGONI CUSPIDATI RHIZOMA, FORSYTHIAE FRUCTUS, and LIGUSTRI FRUCTUS, or contain the herbal ingredients AEGINETIAE HERBA, LONICERAE FLOS, PRUNELLAE SPICA, and LESPEDEZAE HERBA. | ||||||
| 8 | Composition and method for treating premenstrual syndrome | US27147 | 1998-02-20 | US5968518A | 1999-10-19 | Laurie Pike |
| An herbal composition is disclosed comprising as active ingredients chickweed, yarrow, wormwood, motherwort, pennyroyal, and dandelion in a vehicle of olive-oil and beeswax. The composition alleviates cramps, aches and pains, such as those associated with premenstrual syndrome. | ||||||
| 9 | Compositions and methods for the control of smoking | US923199 | 1997-09-04 | US5965625A | 1999-10-12 | Michael Glenn King |
| Compositions for the control of smoking are disclosed, the compositions comprising:(a) an xanthine oxidase inhibitor;(b) a phosphate or a compound capable of releasing phosphate on administration to a subject; and optionally(c) a sugar; and still further optionally(d) one or more pharmaceutically acceptable carriers or excipients.There is also described methods for the control of smoking which comprises administering to a subject in need of such treatment the aforementioned composition. | ||||||
| 10 | Montoxic extract of Larrea tridentata and method of making the same | US152054 | 1998-09-11 | US5945106A | 1999-08-31 | Robert A. Sinnott |
| A nontoxic, therapeutic agent having pharmacological activity comprising concentrated extract of Larrea tridentate plant material and ascorbic acid is made by a process in which the plant material is extracted using an organic solvent, and is then saturated with ascorbic acid to reduce the toxic NDGA quinone, which naturally occurs in the plant material, to NDGA itself. Additional amounts of ascorbic acid are added to the extract to inhibit the natural oxidation of the NDGA into the toxic NDGA quinone in vivo, or during processing or storage. The resulting extract is useful in the treatment of viral diseases caused by viruses from the Herpesviridae family or viruses which require the Sp1 class of proteins to initiate viral replications. The resulting compound can also be used as an anti-inflammatory when the inflammatory diseases are mediated by the effects of leukotrienes. The listed reducing agents can also be used to stabilize NDGA as a therapeutic agent or a food additive. | ||||||
| 11 | Method of metabolic adjuvanation and cellular repair | US898090 | 1997-07-23 | US5895652A | 1999-04-20 | Vincent C. Giampapa |
| A multi-agent tri-daily comestible of vitamin, mineral, plant extracts, aminos, neurochemical precursors, enzymes, and Ph regulating agents which supply key elements necessary for proper metabolization and function of the human body delivered at specific times of the daily biocycle when the need for such specific agents exists in order to maximize the body's extra- and intra-cellular matrix to cellular and biochemical protective and repair mechanisms utilized to deter the effects of otherwise normal aging. | ||||||
| 12 | Natural composition extracted from plants used in the treatment of cancer | US594693 | 1996-01-31 | US5876728A | 1999-03-02 | Howard David Kass; Arnold I. Freeman; Albert Leyva |
| The invention is a method of treating cancer comprising administering an effective amount of either a composition of three herbal extracts consisting essentially of 30% to 70% by weight Goldenseal, 20% to 40% by weight of Myrtle, and 5% to 20% by weight of Centaurea, or a composition of seven herbal extracts consisting essentially of 3% to 5% by weight Centaurea, 1.5% to 4% by weight Capsicum, 1.5% to 4% by weight Lobelia, 20% to 40% by weight Myrrh, 30% to 50% by weight Echinacea, 15% to 25% by weight Goldenseal, and 3% to 5% by weight Myrtle. The compositions were prepared by separately extracting each herb by mixing the herb in water, ethyl alcohol, or a mixture of water and ethyl ether, boiling and cooling the mixture, allowing the mixture to stand for about two weeks, filtering the mixture to obtain the liquid phase, and combining each of said extracts to obtain said compositions. | ||||||
| 13 | Non-irritating capsaicin formulations and applicators therefor | US106834 | 1998-06-30 | US5869533A | 1999-02-09 | Stephen D. Holt |
| A delivery system for applying a formula containing capsaicin together with another ingredient to neutralize the discomfort resulting from the application of capsaicin to the skin which involves the topical application of capsaicin by use of patches, use of second skin, use of sprays and includes a unique method for applying the formulation using laser on the epidermis. | ||||||
| 14 | Skin treatment composition | US863733 | 1997-05-27 | US5869062A | 1999-02-09 | Benjamin Oliver |
| An improved skin treatment composition is provided. The composition comprises calamine in an amount between about 8% and 20%, an antioxidant in an amount between about 0.05 and 3 weight percent; and an herbal anti-bacterial substance in an amount between about 0.25 and 4 weight percent. These ingredients are combined with a base, preferably comprised of water and glycerin, in order to prepare the inventive composition. The base will generally comprise from between 25% and 60% by weight of the overall composition. | ||||||
| 15 | Pain reliever and method of use | US635149 | 1996-04-23 | US5854291A | 1998-12-29 | Timothy R. Laughlin; Stephen D. Holt |
| A composition containing capsaicin together with another ingredient to neutralize the discomfort resulting from the application of capsaicin to the skin can be used to treat many types of discomforts, including arthritis pain, hemorrhoid pain and itching, and poison ivy itching, without the discomfort normally associated with the topical application of capsaicin. | ||||||
| 16 | Bovine mastitis treatment | US547617 | 1995-10-24 | US5846543A | 1998-12-08 | Mark A. Hassler; Lisa M. Hassler |
| Chemical compositions for the treatment of bovine mastitis which compositions are combinations of four components i.e.; Echinechea Goldenseal Supreme; Wild Ginseng Supreme; gelsemium, pokeroot, and aconite; and aloe vera juice, which form a dose which is injected into the mastitis affected portion of a cow's udder for a minimum of two doses per day for at least three days, which results in a cure for the mastitis. | ||||||
| 17 | Nontoxic extract of Larrea tridentata and method of making same | US726686 | 1996-10-07 | US5837252A | 1998-11-17 | Robert A. Sinnott; W. Dennis Clark; Kenneth Frank DeBoer |
| A nontoxic, therapeutic agent having pharmacological activity comprising concentrated extract of Larrea tridentata plant material and ascorbic acid, an ascorbic acid ester, an ascorbic acid salt, butylated hydroxyanisole, butylated hydroxytoluene, hydrogen sulfide, hypophosphorous acid, monothioglycerol, potassium bisulfite, propyl gallate, sodium bisulfite, sodium hydrosulfite, sodium thiosulfate, sulfur dioxide, sulfurous acid, a tocopherol, or vitamin E is made by a process in which the plant material is extracted using an organic solvent, preferably acetone, and is then saturated with one of the listed reducing agents acid to reduce the toxic NDGA quinone, which naturally occurs in the plant material, to NDGA itself. Additional amounts of ascorbic acid, an ascorbic acid ester, an ascorbic acid salt, butylated hydroxyanisole, butylated hydroxytoluene, hydrogen sulfide, hypophosphorous acid, monothioglycerol, potassium bisulfite, propyl gallate, sodium bisulfite, sodium hydrosulfite, sodium thiosulfate, sulfur dioxide, sulfurous acid, a tocopherol, or vitamn E may be added to the extract to inhibit the natural oxidation of the NDGA into the toxic NDGA quinone in vivo, or during processing or storage. The resulting extract is useful in the treatment of viral diseases caused by viruses from the Herpesviridae family or viruses which require the Sp1 class of proteins to initiate viral replications. The resulting compound can also be used as an anti-inflammatory when the inflaatory diseases are mediated by the effects of leukotrienes. The listed reducing agents can also be used to stabilize NDGA as a therapeutic agent or a food additive. | ||||||
| 18 | Composition and method for suppressing or eliminating snoring | US658693 | 1996-06-05 | US5804211A | 1998-09-08 | Lydia Robertson; Edward M. Harris |
| A composition and method are disclosed in which a solution comprising zingiber officinale, dioscorea and a salt are administered to a soft palate and uvula of a host. The solution preferably includes chamomile and a suitable delivery agent that will preferably hold the active ingredients in solution. The solution is preferably administered in the form of a throat spray or nose drop and may also include a flavoring agent. | ||||||
| 19 | Oral administration of therapeutic proteins for treatment of autoimmune disease, transplant rejection and infectious disease | US472712 | 1995-06-05 | US5783193A | 1998-07-21 | J. Gabriel Michael; Allen Litwin |
| An orally administrable therapeutic protein is provided by combining the therapeutic protein with a stabilizing agent in an aqueous solution. The solution is coated onto nonpareils and microencapsulated with a water emulsifiable enteric coating composition. The microcapsules are orally administered. The coating protects the protein as it passes through the stomach. Upon reaching the small intestines, the basic pH of the intestinal juices will dissolve the coating, allowing the protein to be released and induce antigen specific immune response which has the specificity of the native molecule. The stabilizing agent protects the therapeutic protein from denaturation during the encapsulation process. | ||||||
| 20 | Compositions for curing diabetes mellitus, processes for the preparation of same, and usage of same | US550078 | 1995-10-30 | US5773004A | 1998-06-30 | Masakiyo Takahashi |
| Disclosed is the composition for treating or curing diabetes mellitus containing an ingredient or component suitable for treatment of diabetes mellitus from an extract obtained by immersing a plant belonging to genus Tithonia and/or Ludwigia in a pharmacologically acceptable solvent for a predetermined period of time, said plant belonging to genus Tithonia being Tithonia diversifolia (Hemsl.) A. Gray, Tithonia rotundifolia (Mill) Blake, Tithonia fruticosa Canby & Rose, Tithonia scaberrima Benth. or Tithonia longeradiata (Bertol) Brake; and said plant belonging to genus Ludwigia being Ludwigia octovalvis Raven or Ludwigia prostrata Roxb. or Ludwigia epilobioides Maxim. The composition administered in the form of tea or drink or other formulation to a diabetic patient by first applying a composition containing an extract from the plant belonging to genus Tithonia and thereafter applying a composition containing an extract from the plant belonging to genus Ludwigia. The composition for treating diabetes mellitus can alleviate or diminish a variety of symptoms caused by diabetes mellitus or prevailing among diabetic patients, thereby naturally reducing or lowering blood glucose levels to a normal range and preventing diabetes mellitus to be caused to reoccur for a long period of time without continuously administering the composition. | ||||||
QQ群二维码
意见反馈
意见反馈